Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
175M
-
Number of holders
-
113
-
Total 13F shares, excl. options
-
39.8M
-
Shares change
-
+10.5M
-
Total reported value, excl. options
-
$1.4B
-
Value change
-
+$384M
-
Number of buys
-
90
-
Number of sells
-
-32
-
Price
-
$35.19
Significant Holders of Immunovant, Inc. - COMMON STOCK (IMVT) as of Q3 2020
126 filings reported holding IMVT - Immunovant, Inc. - COMMON STOCK as of Q3 2020.
Immunovant, Inc. - COMMON STOCK (IMVT) has 113 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39.8M shares
of 175M outstanding shares and own 22.71% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (7.51M shares), BlackRock Inc. (3.53M shares), VANGUARD GROUP INC (3.18M shares), Cormorant Asset Management, LP (1.64M shares), Polar Capital LLP (1.57M shares), Point72 Asset Management, L.P. (1.51M shares), PERCEPTIVE ADVISORS LLC (1.4M shares), PICTET ASSET MANAGEMENT LTD (1.32M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.31M shares), and BVF INC/IL (1.2M shares).
This table shows the top 113 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.